TABLE 2.
Group (n) | Vascular Injury | % Glomerular Injury | Total HIRD Score | |
---|---|---|---|---|
Score | sclerosis/necrosis | Ischemia | ||
1% NaCl (27) | 15.5±2.2 | 4.4±0.8 | 11.9±2.3 | 35.9±4.9 |
1% NaCl (15) + Enalapril | 2.0±0.7* | 0.3±0.2* | 3.3±1.4* | 5.6±2.3* |
1% NaCl (15) + H&H | 0.1±0.1* | 0.1±0.1* | 0.1±0.1* | 0.6* |
1% NaCl (13) + Amlodipine | 0* | 0* | 0.2±0.2* | 0.6±0.2* |
Histologic renal damage was quantitated in a blinded fashion in perfusion fixed kidneys of untreated salt supplemented SHRsp and those which additionally received enalapril, a combination of hydralazine and hydrochlorothiazide (H&H) or amlodipine (see Methods for details).
p<0.05 maximum vs. the untreated 1% NaCl only group.